ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

Core Viewpoint - ClearPoint Neuro, Inc. will announce its financial results for the fourth quarter and full year of 2025 on March 17, 2026, after market close [1] Company Overview - ClearPoint Neuro is a global device, cell, and gene therapy-enabling company that provides precise navigation to the brain and spine [1] - The company offers both established clinical products and pre-clinical development services for controlled drug and device delivery [1] - Its flagship product, the ClearPoint Neuro Navigation System, has received FDA clearance and is CE-marked [1] - ClearPoint Neuro collaborates with healthcare and research centers across North America, Europe, Asia, and South America, as well as with innovative pharmaceutical and biotech companies [1] Financial Results Announcement - The live broadcast of the financial results will take place on March 17, 2026, at 4:30 p.m. Eastern time [1] - Investors can access the conference call via telephone or online, with a replay available until April 16, 2026 [1] Market Engagement - The company has performed thousands of procedures supported by its field-based clinical specialist team, which provides services to customers and partners worldwide [1]